Abstract:8568 Background: Low dosage computer tomography (LDCT) has been widely adopted as a sensitive method to detect early-stage lung cancer; however, debate regarding its accuracy and overdiagnosis is still ongoing. An accurate non-invasive test is needed to identify malignant nodules and reduce unnecessary invasive procedures. Studies show that plasma proteins and LDCT imaging features may be used to discriminate malignant pulmonary nodules from benign ones. We aimed to develop a combinatorial approach integrating serum protein markers and imaging features to improve the classification of pulmonary nodules. Methods: This study established a prospective research cohort, which enrolled 608 patients of pulmonary nodules. Plasma samples were collected to measure protein levels using Proximity Extension Assay (PEA) technology. The imaging features of the pulmonary nodules were extracted using the python 'radiomics' package. Following feature extraction, a deep learning networks model was built using training cases. The model was then tested in the testing set to evaluate its accuracy and robustness. Results: From the study cohort, 184 benign (BN) and 184 malignant (MT) samples matched for sex and age were chosen to have a representative training set. The rest 240 samples (81 BN and 159 MT) were used as a testing set. Image features were extracted from 448 patients (119 BN and 153 MT in training; 57 BN and 119 MT in testing) with raw LDCT image available. In the testing set, the model trained using only protein levels had an AUC of 0.83 [0.782-0.877] (sensitivity = 71.1% [95% CI 63.6-77.6]; specificity = 82.7% [73.1-89.4]) when classifying plasma samples of lung cancers from those of benign nodules. In comparison, the imaging features-only model had an AUC of 0.874 [0.821-0.916] (sensitivity = 81.5 [73.6-87.5]; specificity = 73.7 [61.0-83.4]). The combinatorial model integrating both protein and imaging features had an AUC of 0.878 [0.830-0.921] (sensitivity = 83.2% [75.5-88.8]; specificity = 77.2% [64.8-86.2]). Notably, the combinatorial model was highly sensitive for early-stage lung cancer, achieving a sensitivity of 93.1% [78.0-98.1] when classifying stage-0 lung cancer cases(n = 29) and 94.8% [85.9-98.2] for stage-I cases (N = 58). Its sensitivity for stage II-IV (n = 7) and clinically diagnosed lung cancers cases (n = 25) were 100% [64.6-100] and 40.0% [23.4-59.3], respectively. Conclusions: This study aimed to construct a model to distinguish malignant pulmonary nodules from benign lung diseases using protein levels and LDCT imaging features. The resulted combinatorial model showed by utilizing both types of features, it was able to accurately differentiate benign and malignant pulmonary nodules, suggesting it may provide guidance for the clinical management of these nodules.

Evaluation of tissue-factor production by human endothelial cells incubated with three acrylic bone cements.

Differences in the dielectric properties of various benign and malignant thyroid nodules

The application value of the tissue dispersion quantitative analysis technique in differentiating thyroid nodules

Microwave dielectric properties of normal, fibroelastotic, and malignant human lung tissue

[Comparison of dielectric properties of normal human esophagus and esophageal cancer using an open-ended coaxial probe]

Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation Study.

Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies

Electrical Conductivity Measurement in Human Liver Tissue: Assessment on Normal vs. Tumor Tissue and under In Vivo vs. Ex Vivo Conditions

Preliminary study on phonetic characteristics of patients with pulmonary nodules

Single‐cell RNA sequencing reveals the multi‐cellular ecosystem in different radiological components of pulmonary part‐solid nodules

Can Spectral Computed Tomography Imaging Improve the Differentiation Between Malignant and Benign Pulmonary Lesions Manifesting As Solitary Pure Ground Glass, Mixed Ground Glass, and Solid Nodules?

A combinatorial model of plasma proteins and LDCT imaging and the diagnosis of pulmonary nodules.

Minimally Invasive Real-Time Electrical Impedance Spectroscopy Diagnostic Tool for Lung Parenchyma Pathologies

P2.06-042 Evaluate the Utility of the Computed Bioconductance Measurement in the Diagnosis of Lung Cancer: Topic: LAB, Other

Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids

Accurate Diagnosis of Pulmonary Nodules Using a Noninvasive DNA Methylation Test.

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules

Electrical impedance characterization of normal and cancerous human hepatic tissue

Not Being There

Diagnostic Value of Spectral CT Parameters in Differentiating Different Types of Lung Cancer